Intelligence Profile
Research Papers
The research on biomarkers and hormonal panels spans multiple studies and clinical trials, focusing on different health conditions and populations.
One study in the Nutrients journal (2026) explored a nutraceutical's impact on oxidative stress biomarkers in healthy individuals and those with Alzheimer's disease. This study indicates a potential therapeutic effect of the combination but lacks details on sample size and specific outcomes, needing further elaboration for clinical implications.
Research published in BMC Infectious Diseases (2025) examined Serum Amyloid A (SAA) as a diagnostic marker for HIV-associated pulmonary infections. It found a correlation between SAA levels and inflammatory markers, suggesting its diagnostic value. However, the study's size and design details are not provided, limiting the depth of the conclusions.
The Food & Function journal (2018) reported on strawberries reducing levels of tumor necrosis factor and lipid peroxides in obese adults with knee osteoarthritis. This indicates an anti-inflammatory effect of strawberries, though specific methodological details like sample size remain unspecified, which is crucial for validating the findings.
A study in Scientific Reports (2016) dealt with serum pharmacodynamic biomarkers for chronic corticosteroid treatment in children, highlighting biomarkers' potential in monitoring therapy but without detailed methodology.
The research from Gastroenterology (2013) identified a link between high-normal levels of alanine aminotransferase and atherogenesis risks, providing insights into liver enzyme levels as predictors for cardiovascular risks.
Another study in Seminars in Nephrology (2012) evaluated new biomarkers, such as neutrophil gelatinase-associated lipocalin, for early detection of acute kidney injury and cardio-renal syndrome, suggesting advanced approaches in early diagnosis but lacking methodological specifics.
An upcoming clinical trial (NCT07731373) named COMPASS-pedPCOS aims to investigate biomarker panels for liver steatosis in adolescents with polycystic ovary syndrome, which is yet to start recruiting.
Overall, while these studies and trials offer promising directions, the lack of detailed sample sizes and comprehensive designs in some makes it challenging to draw robust clinical conclusions. More detailed, large-scale research is essential to validate and expand these findings.
Disclaimer: This summary is for informational purposes only and not a substitute for professional medical advice.